Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 1
2001 2
2003 1
2004 2
2005 8
2006 8
2007 7
2008 9
2009 9
2010 12
2011 18
2012 19
2013 12
2014 5
2015 8
2016 6
2017 2
2018 9
2019 14
2020 7
2021 9
2022 6
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Fragment-to-Lead Medicinal Chemistry Publications in 2020.
de Esch IJP, Erlanson DA, Jahnke W, Johnson CN, Walsh L. de Esch IJP, et al. J Med Chem. 2022 Jan 13;65(1):84-99. doi: 10.1021/acs.jmedchem.1c01803. Epub 2021 Dec 20. J Med Chem. 2022. PMID: 34928151 Free PMC article. Review.
Fragment-to-Lead Medicinal Chemistry Publications in 2021.
Walsh L, Erlanson DA, de Esch IJP, Jahnke W, Woodhead A, Wren E. Walsh L, et al. Among authors: de esch ijp. J Med Chem. 2023 Jan 26;66(2):1137-1156. doi: 10.1021/acs.jmedchem.2c01827. Epub 2023 Jan 9. J Med Chem. 2023. PMID: 36622056 Review.
Fragment-to-Lead Medicinal Chemistry Publications in 2017.
Mortenson PN, Erlanson DA, de Esch IJP, Jahnke W, Johnson CN. Mortenson PN, et al. Among authors: de esch ijp. J Med Chem. 2019 Apr 25;62(8):3857-3872. doi: 10.1021/acs.jmedchem.8b01472. Epub 2018 Nov 21. J Med Chem. 2019. PMID: 30462504 Review.
Structural Analysis of Chemokine Receptor-Ligand Interactions.
Arimont M, Sun SL, Leurs R, Smit M, de Esch IJP, de Graaf C. Arimont M, et al. Among authors: de esch ijp. J Med Chem. 2017 Jun 22;60(12):4735-4779. doi: 10.1021/acs.jmedchem.6b01309. Epub 2017 Mar 10. J Med Chem. 2017. PMID: 28165741 Free PMC article. Review.
Career development in fragment-based drug discovery.
Romasanta AKS, van der Sijde PC, Smit MJ, de Esch IJP, Jahnke W, van Muijlwijk-Koezen JE. Romasanta AKS, et al. Among authors: de esch ijp. Drug Discov Today Technol. 2020 Dec;37:107-116. doi: 10.1016/j.ddtec.2020.10.001. Epub 2020 Dec 1. Drug Discov Today Technol. 2020. PMID: 34895649 Free article. Review.
Fragment-to-Lead Medicinal Chemistry Publications in 2022.
Woodhead AJ, Erlanson DA, de Esch IJP, Holvey RS, Jahnke W, Pathuri P. Woodhead AJ, et al. Among authors: de esch ijp. J Med Chem. 2024 Feb 22;67(4):2287-2304. doi: 10.1021/acs.jmedchem.3c02070. Epub 2024 Jan 30. J Med Chem. 2024. PMID: 38289623 Review.
The Landscape of Atypical and Eukaryotic Protein Kinases.
Kanev GK, de Graaf C, de Esch IJP, Leurs R, Würdinger T, Westerman BA, Kooistra AJ. Kanev GK, et al. Among authors: de esch ijp. Trends Pharmacol Sci. 2019 Nov;40(11):818-832. doi: 10.1016/j.tips.2019.09.002. Epub 2019 Oct 31. Trends Pharmacol Sci. 2019. PMID: 31677919 Free article. Review.
Molecular interaction fingerprint approaches for GPCR drug discovery.
Vass M, Kooistra AJ, Ritschel T, Leurs R, de Esch IJ, de Graaf C. Vass M, et al. Among authors: de esch ij. Curr Opin Pharmacol. 2016 Oct;30:59-68. doi: 10.1016/j.coph.2016.07.007. Epub 2016 Jul 29. Curr Opin Pharmacol. 2016. PMID: 27479316 Review.
Progress in Free Energy Perturbation: Options for Evolving Fragments.
Zara L, Efrém NL, van Muijlwijk-Koezen JE, de Esch IJP, Zarzycka B. Zara L, et al. Among authors: de esch ijp. Drug Discov Today Technol. 2021 Dec;40:36-42. doi: 10.1016/j.ddtec.2021.10.001. Epub 2021 Nov 18. Drug Discov Today Technol. 2021. PMID: 34916020 Review.
170 results